MedPath

Effect of topical application of human breast milk on treatment of infants eczema

Phase 2
Conditions
Infantile atopic dermatitis.
Atopic dermatitis
Registration Number
IRCT201208313869N5
Lead Sponsor
Vice chancellor for research, Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
104
Inclusion Criteria

having less than 20 months and atopic eczema

Exclusion criteria:having major diseases that needed long term treatments

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Extent of infantile atopic eczema. Timepoint: Before intervention and days 7, 14 and 21 after intervention. Method of measurement: Using objective SCORAD and PO SCORAD.
Secondary Outcome Measures
NameTimeMethod
Severity of infantile atopic eczema. Timepoint: Before intervention and days 7, 14 and 21 after intervention. Method of measurement: Using objective SCORAD and PO SCORAD.
© Copyright 2025. All Rights Reserved by MedPath